Evidence-Based Guideline for the Treatment of Androgenetic Alopecia in Women and Men – Short Version

    Varvara Kanti, Andrew G. Messenger, Gustav Dobos, Pascal Reygagne, Andreas Finner, Anja Blumeyer, Myrto Trakatelli, Antonella Tosti, Véronique Del Marmol, Bianca Maria Piraccini, Alexander Nast, Ulrike Blume-Peytavi
    Image of study
    TLDR Use minoxidil for hair loss treatment; assess results after 6 months.
    This document is a summary of an evidence-based guideline for the treatment of androgenetic alopecia (AGA) in men and women. The guideline recommends the use of minoxidil 2% solution twice daily for female patients, and either minoxidil 2% solution twice daily or minoxidil 5% solution or foam applied once daily for male patients. The response to treatment should be assessed at 6 months, and treatment should be continued to maintain efficacy. The main side-effect of topical minoxidil is hypertrichosis, and it is recommended to pause use during pregnancy and lactation. Combination therapy with finasteride 1 mg and 5% minoxidil topical solution led to better improvement than monotherapies in male patients. Dutasteride 0.5 mg daily was also found to be effective in treating AGA in both men and women.
    Discuss this study in the Community →

    Cited in this study

    85 / 85 results